NAYA Biosciences Inc. will make its debut on the Nasdaq on Oct. 22, according to a statement from the newly combined company.

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

Q3 2024 Earnings Call Transcript October 22, 2024 Comstock Inc. misses on earnings expectations. Reported EPS is $-0.07967 ...

Shares of Trump Media DJT, which operates the social-media platform Truth Social, soared earlier this week following Tesla ...

As the 2024 election season heats up, supporters of Donald Trump are looking for ways to express their unwavering loyalty and ...

Despite such challenges, the company evolved into a digital advertising juggernaut, and the profits generated from that business led to Alphabet acquiring numerous other companies. With that expansion ...

The Colossus of Rhodes, a bronze statue of Helios and one of the Seven Wonders stood over 2,000 years ago. Learn about its ...

Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapy ...

The Director-General of the National Orientation Agency, Lanre Issa-Onilu, has emphasised the need for national cohesion, ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that the staff of ...

AI's futuristic vision of Agra depicts a city where tradition and modernity coexist in perfect harmony, the majestic Taj ...